Login

Balance sheets

In USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
ASSETS
Current Assets
   Cash and Cash Equivalents
   Accounts Receivable
   Loan Receivable
Total Current Assets
Fixed Assets
   Vehicles, net
Total Fixed Assets
Other Assets
   Licensing Rights, net
   Distribution Rights
Total Other Assets
Total Assets
Liabilities and Stockholders' (Deficit) Equity
Current Liabilities
   Accrued Compensation
   Accounts Payable and Accrued Liabilities
Accrued Interest SBA Loan
   Note Payable, Current Portion
Total Current Liabilities
   Note Payable, less current portion
Total Liabilities
Stockholders' (Deficit) Equity
   Common Stock $0.001 par value, 75,000,000 shares authorized; 73,200,000 issued and outstanding
   Additional Paid in Capital
   Accumulated Deficit
Total Stockholders’ (Deficit) Equity
Total Liabilities and Stockholders’ (Deficit) Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support